The nuclear epidermal growth factor receptor signaling network and its role in cancer.

The epidermal growth factor receptor (EGFR) is a member of the EGFR family of receptor tyrosine kinases (RTKs). EGFR activation via ligand binding results in signaling through various pathways ultimately resulting in cellular proliferation, survival, angiogenesis, invasion, and metastasis. Aberrant expression or activity of EGFR has been strongly linked to the etiology of several human epithelial cancers including but not limited to head and neck squamous cell carcinoma (HNSCC), non-small cell lung cancer (NSCLC), colorectal cancer (CRC), breast cancer, pancreatic cancer, and brain cancer. Thus intense efforts have been made to inhibit the activity of EGFR by designing antibodies against the ligand binding domains (cetuximab and panitumumab) or small molecules against the tyrosine kinase domain (erlotinib, gefitinib, and lapatinib). Although targeting membrane-bound EGFR has shown benefit, a new and emerging role for EGFR is now being elucidated. In this review we will summarize the current knowledge of the nuclear EGFR signaling network, including how it is trafficked to the nucleus, the functions it serves in the nucleus, and how these functions impact cancer progression, survival, and response to chemotherapeutics.

[1]  S. Bates,et al.  The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance. , 2009, Oncology reports.

[2]  Hiroshi Katayama,et al.  The Aurora kinases: Role in cell transformation and tumorigenesis , 2003, Cancer and Metastasis Reviews.

[3]  W. Xia,et al.  Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression , 2008, Nucleic acids research.

[4]  M. Hung,et al.  Nuclear‐cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1 , 2006, Journal of cellular biochemistry.

[5]  P. Lirk,et al.  Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. , 2005, Seminars in cancer biology.

[6]  M. Hung,et al.  The Translocon Sec61β Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the Nucleus* , 2010, The Journal of Biological Chemistry.

[7]  S. Syrjänen,et al.  Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix. , 1994, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  P. Jeggo,et al.  The life and death of DNA-PK , 2005, Oncogene.

[9]  K. Dittmann,et al.  The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  D. Hochhauser,et al.  EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. , 2011, Cancer research.

[11]  M. Schaller,et al.  Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  A. Ullrich,et al.  A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor , 1986, Nature.

[13]  J. Diehl Cycling to Cancer with Cyclin D1 , 2002, Cancer biology & therapy.

[14]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Kobayashi,et al.  Tyrosine phosphorylation controls PCNA function through protein stability , 2006, Nature Cell Biology.

[16]  D. Rimm,et al.  Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis , 2005, Clinical Cancer Research.

[17]  M. Niepel,et al.  The nuclear pore complex: bridging nuclear transport and gene regulation , 2010, Nature Reviews Molecular Cell Biology.

[18]  M. Hung,et al.  Nuclear EGFR is required for cisplatin resistance and DNA repair. , 2009, American journal of translational research.

[19]  P. Harari,et al.  Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab , 2009, Cancer biology & therapy.

[20]  K. Dittmann,et al.  Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  P. Yue,et al.  A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells , 2011, PloS one.

[22]  Benjamin G. Bitler,et al.  MUC1 regulates nuclear localization and function of the epidermal growth factor receptor , 2010, Journal of Cell Science.

[23]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[24]  G. Carpenter,et al.  Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro , 1978, Nature.

[25]  Yusuke Nakajima,et al.  Co‐regulation of B‐Myb expression by E2F1 and EGF receptor , 2006, Molecular carcinogenesis.

[26]  Michelangelo Foti,et al.  PIKfyve controls fluid phase endocytosis but not recycling/degradation of endocytosed receptors or sorting of procathepsin D by regulating multivesicular body morphogenesis. , 2003, Molecular biology of the cell.

[27]  D. Gomes,et al.  Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway. , 2011, Biochemical and biophysical research communications.

[28]  M. Kanzaki,et al.  Functional Dissection of Lipid and Protein Kinase Signals of PIKfyve Reveals the Role of PtdIns 3,5-P2 Production for Endomembrane Integrity* , 2002, The Journal of Biological Chemistry.

[29]  M. Hung,et al.  Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer , 2009, Molecular carcinogenesis.

[30]  O. Larsson,et al.  SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor , 2010, Science Signaling.

[31]  F. Ali-Osman,et al.  Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes , 2010, Molecular Cancer Research.

[32]  Y. Yatabe,et al.  Throwing new light on lung cancer pathogenesis: Updates on three recent topics , 2005, Cancer science.

[33]  T. Golde,et al.  γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase , 2001, Science.

[34]  S. Bates,et al.  Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance. , 2007, Cancer research.

[35]  P. Lipponen,et al.  Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis. , 1994, British Journal of Cancer.

[36]  T. Helleday,et al.  PCNA on the crossroad of cancer. , 2009, Biochemical Society transactions.

[37]  C. Rao,et al.  Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. , 1995, Endocrinology.

[38]  M. Hung,et al.  Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family* , 2007, Journal of Biological Chemistry.

[39]  M. Schaller,et al.  Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654 , 2010, FEBS letters.

[40]  J. Schlessinger,et al.  Signal transduction by allosteric receptor oligomerization. , 1988, Trends in biochemical sciences.

[41]  G. Carpenter,et al.  Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. , 2007, Molecular biology of the cell.

[42]  K. Dittmann,et al.  Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK , 2008, Molecular Cancer.

[43]  M. Hung,et al.  Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. , 2004, Cancer cell.

[44]  J. Usuda,et al.  Breast cancer resistance protein (BCRP) affected acquired resistance to gefitinib in a "never-smoked" female patient with advanced non-small cell lung cancer. , 2007, Lung cancer.

[45]  G. Carpenter,et al.  Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. , 1975, The Journal of biological chemistry.

[46]  R. Watson,et al.  Cell cycle regulation by the B-Myb transcription factor , 2003, Cellular and Molecular Life Sciences CMLS.

[47]  T. Grunt,et al.  c-erbB-3 , 2002, The Journal of cell biology.

[48]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[49]  M. Mandal,et al.  Physical Interaction between Epidermal Growth Factor Receptor and DNA-dependent Protein Kinase in Mammalian Cells* , 1998, The Journal of Biological Chemistry.

[50]  K. Shigematsu,et al.  Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma. , 1990, Human pathology.

[51]  Qing Jiang,et al.  Roles of Aurora Kinases in Mitosis and Tumorigenesis , 2007, Molecular Cancer Research.

[52]  C. Tzeng,et al.  EGFR Nuclear Import in Gallbladder Carcinoma: Nuclear Phosphorylated EGFR Upregulates iNOS Expression and Confers Independent Prognostic Impact , 2012, Annals of Surgical Oncology.

[53]  M. Hung,et al.  COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport. , 2010, Biochemical and biophysical research communications.

[54]  David J. Chen,et al.  Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase* , 2005, Journal of Biological Chemistry.

[55]  Qingcheng Mao,et al.  Role of the breast cancer resistance protein (ABCG2) in drug transport , 2005, The AAPS Journal.

[56]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[57]  Jayoung Kim,et al.  The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. , 2007, Cancer research.

[58]  P. Yue,et al.  Enhanced Sensitivity of Pancreatic Cancer Cells to Concurrent Inhibition of Aberrant Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor or Src , 2010, Journal of Pharmacology and Experimental Therapeutics.

[59]  S. Cohen,et al.  The stimulation of epidermal proliferation by a specific protein (EGF). , 1965, Developmental biology.

[60]  M. Hung,et al.  Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. , 2005, Cancer research.

[61]  Sheng-Chieh Hsu,et al.  Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. , 2005, Cancer cell.

[62]  A. Harel,et al.  Importin beta: conducting a much larger cellular symphony. , 2004, Molecular cell.

[63]  K. Dittmann,et al.  Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  M. Hung,et al.  Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells* , 2011, The Journal of Biological Chemistry.

[65]  A. Shisheva,et al.  Phosphatidylinositol 3-Phosphate-interacting Domains in PIKfyve , 2002, The Journal of Biological Chemistry.

[66]  C. Ruchti,et al.  Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. , 2001, Thyroid : official journal of the American Thyroid Association.

[67]  N. Jonjić,et al.  Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis , 2010, Modern Pathology.

[68]  S. Kohno,et al.  Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. , 2005, Cancer research.

[69]  Julia B. Cordero,et al.  1,25-Dihydroxyvitamin D Down-regulates Cell Membrane Growth- and Nuclear Growth-promoting Signals by the Epidermal Growth Factor Receptor* , 2002, The Journal of Biological Chemistry.

[70]  K. Dittmann,et al.  The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[71]  M. Hung,et al.  RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus , 2010, Proceedings of the National Academy of Sciences.

[72]  P. Bendinelli,et al.  Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells. , 2009, Carcinogenesis.

[73]  Patricia L. Harris,et al.  Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Cohen,et al.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. , 1962, The Journal of biological chemistry.